Effect of docosahexaenoic acid on oxidative stress in placental trophoblast cells

Early Human Development

Volumn 85, Issue 7, 2009, Pages 433-437

  Shoji, Hiromichi ^a,b   Franke, Corinna ^a   Demmelmair, Hans ^a   Koletzko, Berthold ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; DNA; DOCOSAHEXAENOIC ACID; FATTY ACID; MALONALDEHYDE; PEROXIDE; XANTHINE; XANTHINE OXIDASE;

ARTICLE; CELL CULTURE; CELL SURVIVAL; CELL VIABILITY; DNA DAMAGE; FATTY ACID ANALYSIS; LIPID PEROXIDATION; OXIDATIVE STRESS; TROPHOBLAST;

CELL LINE; CELL SURVIVAL; DEOXYGUANOSINE; DNA DAMAGE; DOCOSAHEXAENOIC ACIDS; FEMALE; HUMANS; HYDROGEN PEROXIDE; LIPID PEROXIDATION; OXIDATIVE STRESS; PLACENTA; TROPHOBLASTS; XANTHINE OXIDASE;

EID: 67349216220     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2009.02.003     Document Type: Article

References (36)

1. Koletzko B., Aggett P.J., Bindels J.G., Bung P., Ferre P., Gil A., et al. Growth, development and differentiation: a functional food science approach. Br J Nutr 80 Suppl 1 (1998) S5-S45
2. Gibson R.A., Neumann M.A., and Makrides M. Effect of dietary docosahexaenoic acid on brain composition and neural function in term infants. Lipids 31 (1996) S177-S181
3. de Urquiza A.M., Liu S., Sjoberg M., Zetterstrom R.H., Griffiths W., Sjovall J., et al. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 290 (2000) 2140-2144
4. Carlson S.E., and Neuringer M. Polyunsaturated fatty acid status and neurodevelopment: a summary and critical analysis of the literature. Lipids 34 (1999) 171-178
5. van Houwelingen A.C., Puls J., and Hornstra G. Essential fatty acid status during early human development. Early Hum Dev 31 (1992) 97-111
6. Birch E.E., Garfield S., Hoffman D.R., Uauy R., and Birch D.G. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev Med Child Neurol 42 (2000) 174-181
7. Willatts P., Forsyth J.S., DiModugno M.K., Varma S., and Colvin M. Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age. Lancet 352 (1998) 688-691
8. Koletzko B. Fatty acids and early human growth. Am J Clin Nutr 73 (2001) 671-672
9. Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol 82 (1997) 291-295
10. Morris J.M., Gopaul N.K., Endresen M.J., Knight M., Linton E.A., Dhir S., et al. Circulating markers of oxidative stress are raised in normal pregnancy and pre-eclampsia. Br J Obstet Gynaecol 105 (1998) 1195-1199
11. Mutlu-Turkoglu U., Ademoglu E., Ibrahimoglu L., Aykac-Toker G., and Uysal M. Imbalance between lipid peroxidation and antioxidant status in preeclampsia. Gynecol Obstet Investig 46 (1998) 37-40
12. Randerath E., Zhou G.D., and Randerath K. Organ-specific oxidative DNA damage associated with normal birth in rats. Carcinogenesis 17 (1996) 2563-2570
13. Takagi Y., Nikaido T., Toki T., Kita N., Kanai M., Ashida T., et al. Levels of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction. Virchows Arch 444 (2004) 49-55
14. Karowicz-Bilinska A., Suzin J., and Sieroszewski P. Evaluation of oxidative stress indices during treatment in pregnant women with intrauterine growth retardation. Med Sci Monit 8 (2002) CR211-CR216
15. Scholl T.O., and Stein T.P. Oxidant damage to DNA and pregnancy outcome. J Matern Fetal Med 10 (2001) 182-185
16. Shoji H., Franke C., Campoy C., Rivero M., Demmelmair H., and Koletzko B. Effect of docosahexaenoic acid and eicosapentaenoic acid supplementation on oxidative stress levels during pregnancy. Free Radic Res 40 (2006) 379-384
17. Wang H., and Joseph J.A. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic Biol Med 27 (1999) 612-616
18. Borenfreund E., and Puerner J.A. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett 24 (1985) 119-124
19. Carnielli V.P., Wattimena D.J., Luijendijk I.H., Boerlage A., Degenhart H.J., and Sauer P.J. The very low birth weight premature infant is capable of synthesizing arachidonic and docosahexaenoic acids from linoleic and linolenic acids. Pediatr Res 40 (1996) 169-174
20. Szitanyi P., Koletzko B., Mydlilova A., and Demmelmair H. Metabolism of 13C-labeled linoleic acid in newborn infants during the first week of life. Pediatr Res 45 (1999) 669-673
21. Schlenzig J.S., Bervoets K., von L.V., and Bohles H. Urinary malondialdehyde concentration in preterm neonates: is there a relationship to disease entities of neonatal intensive care?. Acta Paediatr 82 (1993) 202-205
22. Ibuki Y., Warashina T., Noro T., and Goto R. Coexposure to benzo[a]pyrene plus ultraviolet A induces 8-oxo-7,8-dihydro-2′-deoxyguanosine formation in human skin fibroblasts: preventive effects of anti-oxidant agents. Environ Toxicol Pharmacol 12 (2002) 37-42
23. Toyokuni S., Tanaka T., Hattori Y., Nishiyama Y., Yoshida A., Uchida K., et al. Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest 76 (1997) 365-374
24. Spatling L., Fallenstein F., Huch A., Huch R., and Rooth G. The variability of cardiopulmonary adaptation to pregnancy at rest and during exercise. Br J Obstet Gynaecol 99 Suppl 8 (1992) 1-40
25. Goto Y., Noda Y., Mori T., and Nakano M. Increased generation of reactive oxygen species in embryos cultured in vitro. Free Radic Biol Med 15 (1993) 69-75
26. Gitto E., Reiter R.J., Karbownik M., Tan D.X., Gitto P., Barberi S., et al. Causes of oxidative stress in the pre- and perinatal period. Biol Neonate 81 (2002) 146-157
27. Szajewska H., Horvath A., and Koletzko B. Effect of n-3 long-chain polyunsaturated fatty acid supplementation of women with low-risk pregnancies on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials. Am J Clin Nutr 83 (2006) 1337-1344
28. Horvath A., Koletzko B., and Szajewska H. Effect of supplementation of women in high-risk pregnancies with long-chain polyunsaturated fatty acids on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials. Br J Nutr 98 (2007) 253-259
29. Nair P.P., Judd J.T., Berlin E., Taylor P.R., Shami S., Sainz E., et al. Dietary fish oil-induced changes in the distribution of alpha-tocopherol, retinol, and beta-carotene in plasma, red blood cells, and platelets: modulation by vitamin E. Am J Clin Nutr 58 (1993) 98-102
30. Wander R.C., and Du S.H. Oxidation of plasma proteins is not increased after supplementation with eicosapentaenoic and docosahexaenoic acids. Am J Clin Nutr 72 (2000) 731-737
31. Barden A.E., Mori T.A., Dunstan J.A., Taylor A.L., Thornton C.A., Croft K.D., et al. Fish oil supplementation in pregnancy lowers F2-isoprostanes in neonates at high risk of atopy. Free Radic Res 38 (2004) 233-239
32. Many A., Hubel C.A., and Roberts J.M. Hyperuricemia and xanthine oxidase in preeclampsia, revisited. Am J Obstet Gynecol 174 (1996) 288-291
33. Many A., Hubel C.A., Fisher S.J., Roberts J.M., and Zhou Y. Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol 156 (2000) 321-331
34. Gonzalez-Periz A., Planaguma A., Gronert K., Miquel R., Lopez-Parra M., Titos E., et al. Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA. FASEB J 20 (2006) 2537-2539
35. Arab K., Rossary A., Flourie F., Tourneur Y., and Steghens J.P. Docosahexaenoic acid enhances the antioxidant response of human fibroblasts by upregulating gamma-glutamyl-cysteinyl ligase and glutathione reductase. Br J Nutr 95 (2006) 18-26
36. Brown E.R., and Subbaiah P.V. Differential effects of eicosapentaenoic acid and docosahexaenoic acid on human skin fibroblasts. Lipids 29 (1994) 825-829